Article
A novel platform to produce human monoclonal antibodies: The next generation of therapeutic human monoclonal antibodies discovery.
mAbs - 1 Jan 2000
Duvall Marcus, Bradley Norma, Fiorini Ryan N
Abstract excerpt
A new technology has been developed that allows human antibodies to be quickly generated against virtually any antigen. Using a novel process, naïve human B cells are isolated from tonsil tissue and transformed with efficiency up to 85%, thus utilizing a large portion of the human VDJ/VJ repertoire. Through ex vivo stimulation, the B cells class switch and may undergo somatic hypermutation, thus producing a human...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
